LESSON PLAN PER SEMESTER (RPKPS)
SUBJECT : PHARMACOTHERAPY II
(3,0)
LECTURERS:
1. Prof. Dr. Helmi Arifin, MS, Apt.
2. Prof. Dr. Armenia, MS, Apt
3. Prof. Dr. Almahdy A, MS, Apt
4. Rahmi Yosmar, M.Farm, Apt
5. Dian Ayu Juwita, M.Farm, Apt
FACULTY OF PHARMACY
ANDALAS UNIVERSITY
PADANG
2013
LESSON PLAN PER SEMESTER (RPKPS)
Pharmacotherapy II (3,0)
A. Course Plan
1. Description
This course describes the pharmacotherapy several cardiovascular
disorders and renal disorders. Consisting of cardiovascular disorders are
Cardiovascular Testing, Cardiopulmonary Resuscitation, Hypertension, Heart
Failure, Ischemic Heart Disease, acute Coronary Syndromes, arrhythmias,
diastolic Heart Failure and the Cardiomyopathies.
2. General Learning Outcome
After taking the Pharmacotherapy II students are able to choose the
treatment. The treatment section may include nonpharmacologic therapy, drug
selection guidelines, dosing recommendations, adverse effects, pharmacokinetic
considerations, and important drug–drug interactions.
3. Specific Learning Outcomes
After completion of this course, students are able to :
1. Understanding the pathophysiology of cardiovascular disorders
2. Were able to choose the appropriate therapy for any cardiovascular disorder
3. Capable of providing the appropriate non-pharmacological treatment for
cardiovascular disorders
4. Understanding the pathophysiology of renal disorders
5. Were able to choose the appropriate therapy for any renal disorders
6. Capable of providing the appropriate non-pharmacological treatment for
renal disorders
B. Teaching and Learning Process
1. Time Table
Pertemuan
Week 1
Week 2
Topik
Substansi
Metode
Fasilitas
CARDIOVASCULAR Cardiovascular Testing
Discussion, - WB
DISORDERS
case study
- LCD
Cardiopulmonary
Discussion, - WB
Resuscitation
case study
- LCD
Week 3
Discussion, - WB
Hypertension
case study
Week 4
Discussion, - WB
Heart Failure
case study
Week 5
Ischemic Heart Disease
Acute
Week 7
Week 9
Week 10
Syndromes
case study
Arrhythmias
Discussion, - WB
- LCD
- LCD
Diastolic Heart Failure and Discussion, - WB
the Cardiomyopathies
case study
RENAL
Quantification of Renal
Discussion, - WB
DISORDERS
Function
case study
Acute Renal Failure
Discussion, - WB
case study
Week 11
- LCD
Coronary Discussion, - WB
case study
Week 8
- LCD
Discussion, - WB
case study
Week 6
- LCD
Chronic Kidney Disease:
Progression-Modifying
- LCD
- LCD
- LCD
Discussion, - WB
case study - LCD
Therapies
Week 12
Chronic Kidney Disease:
Therapeutic Approach for
Discussion, - WB
case study - LCD
the Management of
Complications
Week 13
Hemodialysis and
Peritoneal Dialysis
Week 14
Drug-Induced Kidney
Disease
Discussion, - WB
case study - LCD
Discussion, - WB
case study - LCD
Glomerulonephritis
Week 15
Discussion, - WB
case study
Week 16
- LCD
Drug Therapy
Discussion, - WB
Individualization for
case study
- LCD
Patients with Renal
Insufficiency
2. Study Method
-
Discussion
Lecturer gives short description about topic of the week. This description
contains definition, drug action mechanism, pharmacotherapy management and,
disease guideline. At the end of one session lecturer gives some examples of
cases which should be solve on the next session.
-
Case study
Student was divided into several groups. Each group solve the case that lecturer
has already given. Conclusion and case solving will be talked on the next
session.
C. Study Evaluation
1. Result
Result is given from capability of student on attending the class, activity of
discussion, and creativity of solving the cases. Assessment was held along the
semester through activity of discussion, mid semester, and at the end of semester.
Student who has great view on concept will get the highest score and vice versa.
Monitoring and tracer study from student will be collected through data quotionaire.
2. Assessment
Assessment
Assessment Element
Presentation
Aspect
Comprehension
Soft Skills
(%)
Home work
10 - 20
Mid semester
20 – 30
Full semester
20 – 40
Creativity on discussion and resume,
10 - 30
discipline
on
work
schedule,
class
participation.
Total
100
D. References
1. Wells B.G, et al, 2009, Pharmacotherapy Handbook, 7 th ed, McGraw-Hill
company, New York, United States of America
2. Oxford of Clinical Pharmacotherapy Handbook